NYSE Biotech Stock
Covance is a leading drug development services company providing a wide range of early-stage and late-stage product development services
on a
worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries. Covance also provides services such as laboratory testing to the ...
more
The Company believes that the concentration of credit risk with respect to clinical laboratory's accounts receivable is limited due to the diversity of the various numbers of third party insurance carriers, the Federal Medicare Program and the numerous individual patient accounts. Revenue, net of contractual adjustments, from direct billings under the Federal Medicare program during the ...
more
Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") is a global provider of products and technologies that are designed to treat advanced
cardiovascular disease. Edwards Lifesciences focuses on providing products and technologies to address specific cardiovascular opportunities: heart valve disease; peripheral vascular ...
more
Delta and Pine Land Company, a Delaware corporation, and subsidiaries ("D&PL") is primarily engaged in the breeding, production, conditioning and marketing of proprietary varieties of cotton planting seed in the United States and other cotton producing nations. We also breed, produce, condition and market soybean planting seed in the United States.
more
Hillenbrand Industries, Inc. was incorporated on August 7, 1969 in the State of Indiana and is
headquartered in Batesville, Indiana. Hillenbrand is a public holding company for its two major
operating businesses serving the health care and funeral services industries in the United States
and abroad.
more
CryoLife, Inc. (“CryoLife”, the “Company”, “we”, or “us”), incorporated January 19, 1984 in Florida, develops
and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications. The Company’s biomaterials and implantable devices include BioGlue ® ...
more
•
Specialty Generics: development, licensing and sales of generic and branded generic
pharmaceutical products and active pharmaceutical ingredients, or API, and the
manufacturing of pharmaceuticals for others; and
more
We design, manufacture and distribute a broad array of valves and related fluid control products and services to a variety of end-markets
for use in a wide range of applications to optimize the efficiency and/or ensure the safety of fluid-control systems. We have a global presence and operate 18 significant manufacturing facilities that are located in the United States, Canada,
Western Europe ...
more
We operate our business exclusively through our direct and indirect subsidiaries, including ISP Opco Holdings Inc., ISP Chemicals Inc., ISP Technologies Inc., ISP Van Dyk Inc., ISP Fine Chemicals Inc., ISP Freetown Fine Chemicals Inc. and ISP Alginates Inc. We were incorporated in Delaware in 1996.
more
We are one of the largest pharmaceutical services companies in the United States, with net revenue of approximately $36.8 billion (including approximately
$5.8 billion of retail copayments) in 2006. Our operations are conducted primarily through our Caremark Inc. (“Caremark”) and CaremarkPCS (f/k/a AdvancePCS) (“CaremarkPCS” or “AdvancePCS”) subsidiaries.
more
